Short Interest in Vimian Group AB (publ) (OTCMKTS:VIMGF) Decreases By 11.5%

Vimian Group AB (publ) (OTCMKTS:VIMGFGet Free Report) was the target of a significant drop in short interest in February. As of February 15th, there was short interest totalling 78,500 shares, a drop of 11.5% from the January 31st total of 88,700 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 785.0 days.

Vimian Group AB (publ) Stock Performance

OTCMKTS:VIMGF opened at C$3.50 on Friday. Vimian Group AB has a 52-week low of C$2.68 and a 52-week high of C$4.12. The stock has a 50-day simple moving average of C$3.52 and a 200 day simple moving average of C$3.71.

About Vimian Group AB (publ)

(Get Free Report)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.

Read More

Receive News & Ratings for Vimian Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vimian Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.